Global Point of Care (POC) Drugs of Abuse Testing Market, By Drugs Type (Amphetamines, Barbiturates, Benzodiazepines, Cannibinoids, Cocaine, Methadone, Opiates, Phencyclidine), Product (Analysers, Rapid Testing Devices, Consumables), Sample Type (Saliva, Urine, Blood, Others), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Point of Care (POC) Drugs of Abuse Testing Market
Global point of care (POC) drugs of abuse testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 1625.14 million in 2020 to USD 2311.12 million by 2028 growing at a CAGR of 4.50% in the above-mentioned forecast period.
Drugs of abuse is basically the illegal prescribed substances consumed for a non-medical purpose. The point of care (POC) drugs of abuse testing deals with the detection of illegal substances in the urine, blood, saliva, hair or sweat which is done at a specified testing location rather than the sample being sent to a laboratory.
The high prevalence of drug abuse in individuals especially teenagers and the usage of point of care drugs of abuse testing in sports are primarily driving the growth of the point of care (POC) drugs of abuse testing market. Additionally, the known advantages of point of care drugs of abuse testing such as reduced potential for contamination or deterioration, fewer requirements to aliquot specimens or store samples and portability are the reason for high adoption and usage of point of care (POC) drugs of abuse testing. On the other hand, the point of care testing devices may not be as reliable and accurate as compared to the laboratory-based testing’s due to high probability of falser positive or negative results which might restrain the overall growth of the market. The increasing number of regulatory approvals for and the rising usage of home-based point of care devices is estimated to generate new opportunities within the forecast period.
However, the factor such as narrow detection range and less ability to differentiate between similar drugs in same category in the testing is projected to be major challenge for the market’s growth.
This point of care (POC) drugs of abuse testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research point of care (POC) drugs of abuse testing market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of care (POC) Drugs of Abuse Testing Market Scope and Market Size
Point of care (POC) drugs of abuse testing market is segmented on the basis of drugs type, product, sample type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drugs type, the point of care (POC) drugs of abuse testing market is bifurcated into amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiates and phencyclidine.
- On the basis of product, the market is segmented into analysers, rapid testing devices and consumables. Analysers are further segmented into immunoassays, chromatographic devices and breath analysers. Rapid testing devices are further segmented into urine testing devices and oral fluid testing devices.
- On the basis of sample type, the market is segregated into saliva, urine, blood and others.
- On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, forensic laboratories and others.
Point of care (POC) Drugs of Abuse Testing Market Country Level Analysis
Point of care (POC) drugs of abuse testing market is analysed and market size insights and trends are provided by drugs type, product, sample type and end-user as referenced above.
The countries covered in the point of care (POC) drugs of abuse testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point of care (POC) drugs of abuse testing market due to the rise in consumption of drugs of abuse in this region in the region. Asia-Pacific is expected to grow at the fastest rate in the forecast period of 2021 to 2028 due to the presence of high population base and high adoption of point of care kits OTC testing.
The country section of the point of care (POC) drugs of abuse testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Point of care (POC) drugs of abuse testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for point of care (POC) drugs of abuse testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) drugs of abuse testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point of care (POC) Drugs of Abuse Testing Market Share Analysis
Point of care (POC) drugs of abuse testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care (POC) drugs of abuse testing market.
The major players covered in the point of care (POC) drugs of abuse testing market report are uest Diagnostics Incorporated, Abbott, AdvaCare Pharma, Cliawaived Inc., DRUGSCAN, Millennium Health, BD, Agilent Technologies Inc., Danaher, Bio-Rad Laboratories Inc., Cellavision, JOYSBIO (Tianjin) Biotechnology Co., Ltd, NIHON KOHDEN CORPORATION, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Sysmex Corporation, Merck KGaA, Cardinal Health, Takara Bio Inc., bioMérieux SA, Enzo Life Sciences Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-